Cargando…

Correction: Díaz-Talavera et al. PrimPol: A Breakthrough among DNA Replication Enzymes and a Potential New Target for Cancer Therapy. Biomolecules 2022, 12, 248

Detalles Bibliográficos
Autores principales: Díaz-Talavera, Alberto, Montero-Conde, Cristina, Leandro-García, Luis Javier, Robledo, Mercedes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138727/
https://www.ncbi.nlm.nih.gov/pubmed/35625665
http://dx.doi.org/10.3390/biom12050693
_version_ 1784714691997597696
author Díaz-Talavera, Alberto
Montero-Conde, Cristina
Leandro-García, Luis Javier
Robledo, Mercedes
author_facet Díaz-Talavera, Alberto
Montero-Conde, Cristina
Leandro-García, Luis Javier
Robledo, Mercedes
author_sort Díaz-Talavera, Alberto
collection PubMed
description
format Online
Article
Text
id pubmed-9138727
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-91387272022-05-28 Correction: Díaz-Talavera et al. PrimPol: A Breakthrough among DNA Replication Enzymes and a Potential New Target for Cancer Therapy. Biomolecules 2022, 12, 248 Díaz-Talavera, Alberto Montero-Conde, Cristina Leandro-García, Luis Javier Robledo, Mercedes Biomolecules Correction MDPI 2022-05-12 /pmc/articles/PMC9138727/ /pubmed/35625665 http://dx.doi.org/10.3390/biom12050693 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Correction
Díaz-Talavera, Alberto
Montero-Conde, Cristina
Leandro-García, Luis Javier
Robledo, Mercedes
Correction: Díaz-Talavera et al. PrimPol: A Breakthrough among DNA Replication Enzymes and a Potential New Target for Cancer Therapy. Biomolecules 2022, 12, 248
title Correction: Díaz-Talavera et al. PrimPol: A Breakthrough among DNA Replication Enzymes and a Potential New Target for Cancer Therapy. Biomolecules 2022, 12, 248
title_full Correction: Díaz-Talavera et al. PrimPol: A Breakthrough among DNA Replication Enzymes and a Potential New Target for Cancer Therapy. Biomolecules 2022, 12, 248
title_fullStr Correction: Díaz-Talavera et al. PrimPol: A Breakthrough among DNA Replication Enzymes and a Potential New Target for Cancer Therapy. Biomolecules 2022, 12, 248
title_full_unstemmed Correction: Díaz-Talavera et al. PrimPol: A Breakthrough among DNA Replication Enzymes and a Potential New Target for Cancer Therapy. Biomolecules 2022, 12, 248
title_short Correction: Díaz-Talavera et al. PrimPol: A Breakthrough among DNA Replication Enzymes and a Potential New Target for Cancer Therapy. Biomolecules 2022, 12, 248
title_sort correction: díaz-talavera et al. primpol: a breakthrough among dna replication enzymes and a potential new target for cancer therapy. biomolecules 2022, 12, 248
topic Correction
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138727/
https://www.ncbi.nlm.nih.gov/pubmed/35625665
http://dx.doi.org/10.3390/biom12050693
work_keys_str_mv AT diaztalaveraalberto correctiondiaztalaveraetalprimpolabreakthroughamongdnareplicationenzymesandapotentialnewtargetforcancertherapybiomolecules202212248
AT monterocondecristina correctiondiaztalaveraetalprimpolabreakthroughamongdnareplicationenzymesandapotentialnewtargetforcancertherapybiomolecules202212248
AT leandrogarcialuisjavier correctiondiaztalaveraetalprimpolabreakthroughamongdnareplicationenzymesandapotentialnewtargetforcancertherapybiomolecules202212248
AT robledomercedes correctiondiaztalaveraetalprimpolabreakthroughamongdnareplicationenzymesandapotentialnewtargetforcancertherapybiomolecules202212248